Press "Enter" to skip to content

Motilal Oswal Recommends BUY on PPL Pharma with Target Price of Rs 260

By bigbreakingwire on September 30, 2024

Motilal Oswal has issued a BUY recommendation on PPL Pharma with a target price of Rs 260, indicating a potential upside of 14.89% from the current price of Rs 226.31.

Published in Brokerage Reports

bigbreakingwire
bigbreakingwire

Bringing you the latest updates on finance, economies, stocks, bonds, and more. Stay informed with timely insights.

More from Brokerage ReportsMore posts in Brokerage Reports »

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *